New Strong Buy Stocks for February 13th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Synchrony Financial SYF: This consumer financial services company has seen the Zacks Consensus Estimate for its current year earnings increasing 18.2% over the last 60 days.
$Synchrony Financial(SYF-B)$ Price and Consensus
Synchrony Financial price-consensus-chart | Synchrony Financial Quote
SouthState Corporation SSB: This bank holding company for SouthState Bank has seen the Zacks Consensus Estimate for its current year earnings increasing 7.8% over the last 60 days.
SouthState Corporation Price and Consensus
SouthState Corporation price-consensus-chart | SouthState Corporation Quote
Veracyte, Inc. VCYT: This diagnostics company has seen the Zacks Consensus Estimate for its current year earnings increasing 20.4% over the last 60 days.
Veracyte, Inc. Price and Consensus
Veracyte, Inc. price-consensus-chart | Veracyte, Inc. Quote
Day One Biopharmaceuticals, Inc. DAWN: This clinical-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 17.1% over the last 60 days.
Day One Biopharmaceuticals, Inc. Price and Consensus
Day One Biopharmaceuticals, Inc. price-consensus-chart | Day One Biopharmaceuticals, Inc. Quote
Financial Institutions, Inc. FISI: This holding company for the Five Star Bank has seen the Zacks Consensus Estimate for its current year earnings increasing 7.5% over the last 60 days.
Financial Institutions, Inc. Price and Consensus
Financial Institutions, Inc. price-consensus-chart | Financial Institutions, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Financial Institutions, Inc. (FISI) : Free Stock Analysis Report
Synchrony Financial (SYF) : Free Stock Analysis Report
Veracyte, Inc. (VCYT) : Free Stock Analysis Report
SouthState Corporation (SSB) : Free Stock Analysis Report
Day One Biopharmaceuticals, Inc. (DAWN) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Most Discussed
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10